Publications

Publications

The faculty of the Department of Obstetrics and Gynecology have authored hundreds of publications. A fully searchable index of publications is below.

Searchable Index

To filter the list, type a name, term or title into the Search field.

NameTitle
Bradley, William H., MDGretz H, Bradley WH, Zakashansky K, Nezhat F, Rahaman J, Chuang L, Bohren DL, Kreiger K, Rubin E, Sokolow A. Patient clinical factors influencing use of hysterectomy in New York, 2001-2005. Am J Obstet Gynecol. 2008 Oct;199(4):349.e1-5.
Bradley, William H., MDGretz H, Bradley WH, Zakashansky K, Nezhat F, Bohren DL, Kreiger K, Rubin E, Sokolow A. Effect of physician gender and specialty on utilization of hysterectomy in New York, 2001-2005. Am J Obstet Gynecol. 2008 Oct;199(4):347.e1-6.
Bradley, William H., MDBradley WH, Dottino PR, Rahaman J. Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation. Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1364-7.
Bradley, William H., MDZakashansky K, Bradley WH, Nezhat FR. New techniques in radical hysterectomy. Curr Opin Obstet Gynecol. 2008 Feb;20(1):14-9.
Bradley, William H., MDBradley WH, Lima PH, Rodgers L, Blomquist CH, Downs LS. Endometrial carcinoma expresses an increased cathepsin B/D ratio. Gynecol Oncol. 2008 Jan;108(1):84-9.
Bradley, William H., MDLeath CA 3rd, Huh WK, Hyde J Jr, Cohn DE, Resnick KE, Taylor NP, Powell MA, Mutch DG, Bradley WH, Geller MA, Argenta PA, Gold MA. A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol. 2007 Jun;105(3):630-4.
Bradley, William H., MDGeller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF, Boente MP. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol. 2004 Dec;95(3):632-6.
Bradley, William H., MDBradley WH, Boente MP, Brooker D, Argenta PA, Downs LS, Judson PL, Carson LF. Hysteroscopy and cytology in endometrial cancer. Obstet Gynecol. 2004 Nov;104(5 Pt 1):1030-3.
Broekhuizen, Fredrik F., MDBroekhuizen FF. Emergency contraception, efficacy and public health impact. Curr Opin Obstet Gynecol. 2009 Aug;21(4):309-12.
Broekhuizen, Fredrik F., MDJacob M, Broekhuizen FF, Castro W, Sellors J. Experience using cryotherapy for treatment of cervical precancerous lesions in low-resource settings. Int J Gynaecol Obstet. 2005 May;89 Suppl 2:S13-20.
Broekhuizen, Fredrik F., MDBroekhuizen FF. A low-resource, simple method to treat postpartum hemorrhage. MedGenMed. 2003 Sep 12;5(3):39.
Broekhuizen, Fredrik F., MDEvans W, Lensmeyer JP, Kirby RS, Malnory ME, Broekhuizen FF. Two-hour urine collection for evaluating renal function correlates with 24-hour urine collection in pregnant patients. J Matern Fetal Med. 2000 Jul-Aug;9(4):233-7.
Broekhuizen, Fredrik F., MDVeligati P, Broekhuizen FF, Kirby RS, Malnory M. A randomized trial comparing prostaglandin E(2) vaginal insert (Cervidil) to vaginal gel for cervical ripening before induction of labor. Prim Care Update Ob Gyns. 1998 Jul 1;5(4):182.
Broekhuizen, Fredrik F., MDBeckmann CA, Van Mullem C, Beckmann CR, Broekhuizen FF. Interpreting fetal heart rate tracings. Is there a difference between labor and delivery nurses and obstetricians? J Reprod Med. 1997 Oct;42(10):647-50.
Broekhuizen, Fredrik F., MDHanion-Lundberg KM, Kirby RS, Gandhi S, Broekhuizen FF. Nucleated red blood cells in cord blood of singleton term neonates. Am J Obstet Gynecol. 1997 Jun;176(6):1149-54; discussion 1154-6.
Broekhuizen, Fredrik F., MDPollnow DM, Broekhuizen FF. Randomized, double-blind trial of prostaglandin E2 intravaginal gel versus low-dose oxytocin for cervical ripening before induction of labor. Am J Obstet Gynecol. 1996 Jun;174(6):1910-3; discussion 1913-6.
Broekhuizen, Fredrik F., MDPascoe JM, Kokotailo PK, Broekhuizen FF. Correlates of multigravida women's binge drinking during pregnancy. A longitudinal study. Arch Pediatr Adolesc Med. 1995 Dec;149(12):1325-9.
Broekhuizen, Fredrik F., MDEltabbakh GH, Eltabbakh GD, Broekhuizen FF, Griner BT. Value of wet mount and cervical cultures at the time of cervical cytology in asymptomatic women. Obstet Gynecol. 1995 Apr;85(4):499-503.
Broekhuizen, Fredrik F., MDElTabbakh GH, Elejalde BR, Broekhuizen FF. Primary syphilis and nonimmune fetal hydrops in a penicillin-allergic woman. A case report. J Reprod Med. 1994 May;39(5):412-4.
Broekhuizen, Fredrik F., MDel-Tabbakh GH, Broekhuizen FF. Spontaneous quadruplet pregnancy in a woman with a personal and family history of spontaneous twin and triplet pregnancy. A case report. J Reprod Med. 1994 Feb;39(2):134-6.
Broekhuizen, Fredrik F., MDBroekhuizen FF, Boyles ME, Utrie J. The effect of urban socioeconomic problems on perinatal statistics in Milwaukee, 1983-1991. Wis Med J. 1993 May;92(5):243-7.
Broekhuizen, Fredrik F., MDVan Le L, Broekhuizen FF, Janzer-Steele R, Behar M, Samter T. Acetic acid visualization of the cervix to detect cervical dysplasia. Obstet Gynecol. 1993 Feb;81(2):293-5.
Broekhuizen, Fredrik F., MDBroekhuizen FF, Utrie J, Van Mullem C. Drug use or inadequate prenatal care? Adverse pregnancy outcome in an urban setting. Am J Obstet Gynecol. 1992 Jun;166(6 Pt 1):1747-54; discussion 1754-6.
Broekhuizen, Fredrik F., MDThomason JL, Gelbart SM, Kellett AV, Scaglione NJ, Gotwalt KT, Broekhuizen FF. Terconazole for the treatment of vulvovaginal candidiasis. J Reprod Med. 1990 Nov;35(11):992-4.
Broekhuizen, Fredrik F., MDThomason JL, Kellett AV, Gelbart SM, James JA, Broekhuizen FF. Short-course erythromycin therapy for endocervical chlamydia during pregnancy. J Fam Pract. 1990 Jun;30(6):711-2.
Broekhuizen, Fredrik F., MDGelbart SM, Thomason JL, Osypowski PJ, Kellett AV, James JA, Broekhuizen FF. Growth of Trichomonas vaginalis in commercial culture media. J Clin Microbiol. 1990 May;28(5):962-4.
Broekhuizen, Fredrik F., MDThomason JL, Gelbart SM, Monagle LM, James JA, Broekhuizen FF. Is pH test paper as accurate as the electronic measurement of the pH of vaginal secretions? Am J Obstet Gynecol. 1990 May;162(5):1213-4.
Broekhuizen, Fredrik F., MDThomason JL, Gelbart SM, Anderson RJ, Walt AK, Osypowski PJ, Broekhuizen FF. Statistical evaluation of diagnostic criteria for bacterial vaginosis. Am J Obstet Gynecol. 1990 Jan;162(1):155-60.
Broekhuizen, Fredrik F., MDThomason JL, Gelbart SM, James JA, Broekhuizen FF. Vaginitis in reproductive-age women. Curr Opin Obstet Gynecol. 1989 Oct;1(1):35-41.
Broekhuizen, Fredrik F., MDThomason JL, Gelbart SM, Broekhuizen FF. Advances in the understanding of bacterial vaginosis. J Reprod Med. 1989 Aug;34(8 Suppl):581-6; discussion 586-7.
Broekhuizen, Fredrik F., MDGalvan BJ, Van Mullem C, Broekhuizen FF. Using amnioinfusion for the relief of repetitive variable decelerations during labor. J Obstet Gynecol Neonatal Nurs. 1989 May-Jun;18(3):222-9.
Broekhuizen, Fredrik F., MDGalvan BJ, Broekhuizen FF. Obstetric vacuum extraction. J Obstet Gynecol Neonatal Nurs. 1987 Jul-Aug;16(4):242-8.
Broekhuizen, Fredrik F., MDBroekhuizen FF, Washington JM, Johnson F, Hamilton PR. Vacuum extraction versus forceps delivery: indications and complications, 1979 to 1984. Obstet Gynecol. 1987 Mar;69(3 Pt 1):338-42.
Broekhuizen, Fredrik F., MDBroekhuizen FF, Gilman M, Hamilton PR. Amniocentesis for gram stain and culture in preterm premature rupture of the membranes. Obstet Gynecol. 1985 Sep;66(3):316-21.
Broekhuizen, Fredrik F., MDBroekhuizen FF, Fox R. Computerized labor and delivery logbook. A first step to a perinatal database in a university-affiliated community hospital. Am J Perinatol. 1985 Apr;2(2):150-3.
Broekhuizen, Fredrik F., MDHamilton PR, Broekhuizen FF. Acute intermittent porphyria and hydatid mole: etiology of hyperthyroidism. Am J Obstet Gynecol. 1984 May 15;149(2):226-7.
Broekhuizen, Fredrik F., MDBroekhuizen FF, Hamilton PR. Pseudoxanthoma elasticum and intrauterine growth retardation. Am J Obstet Gynecol. 1984 Jan 1;148(1):112-4.
Broekhuizen, Fredrik F., MDHamilton PR, Hauschild D, Broekhuizen FF, Beck RM. Comparison of lecithin: sphingomyelin ratio, fluorescence polarization, and phosphatidylglycerol in the amniotic fluid in the prediction of respiratory distress syndrome. Obstet Gynecol. 1984 Jan;63(1):52-6.
Broekhuizen, Fredrik F., MDBroekhuizen FF, de Elejalde M, Elejalde R, Hamilton PR. Neonatal myotonic dystrophy as a cause of hydramnios and neonatal death. A case report and literature review. J Reprod Med. 1983 Sep;28(9):595-9.
Broekhuizen, Fredrik F., MDBroekhuizen FF, Elejalde R, Hamilton PR. Early-onset preeclampsia, triploidy and fetal hydrops. J Reprod Med. 1983 Mar;28(3):223-6.
Broekhuizen, Fredrik F., MDBroekhuizen FF, Haning RV Jr, Shapiro SS. Laparoscopic findings in twenty-five failures of artificial insemination. Fertil Steril. 1980 Oct;34(4):351-5.
Huang, Yi-Wen, PhDRivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV.   Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.   Breast Cancer Res.   2012 May 14;14(3):R77.
Huang, Yi-Wen, PhDYeh KT, Chen TH, Yang HW, Chou JL, Chen LY, Yeh CM, Chen YH, Lin RI, Su HY, Chen GC, Deatherage DE, Huang YW, Yan PS, Lin HJ, Nephew KP, Huang TH, Lai HC, Chan MW.   Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.   Epigenetics.   2011 Jun;6(6):727-39.
Huang, Yi-Wen, PhDOzer HG, Huang YW, Wu J, Parvin JD, Huang TH, Huang K.   Comparing multiple ChIP-sequencing experiments.   J Bioinform Comput Biol.   2011 Apr;9(2):269-82.
Huang, Yi-Wen, PhDWang QE, Milum K, Han C, Huang YW, Wani G, Thomale J, Wani AA.   Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells.   Mol Cancer.   2011;10:24.
Huang, Yi-Wen, PhDSun S, Chen Z, Yan PS, Huang YW, Huang TH, Lin S.   Identifying hypermethylated CpG islands using a quantile regression model.   BMC Bioinformatics.   2011;12:54.
Huang, Yi-Wen, PhDZuo T, Liu TM, Lan X, Weng YI, Shen R, Gu F, Huang YW, Liyanarachchi S, Deatherage DE, Hsu PY, Taslim C, Ramaswamy B, Shapiro CL, Lin HJ, Cheng AS, Jin VX, Huang TH.   Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer.   Cancer Res.   2011 Mar 1;71(5):1752-62.
Huang, Yi-Wen, PhDWang LS, Arnold M, Huang YW, Sardo C, Seguin C, Martin E, Huang TH, Riedl K, Schwartz S, Frankel W, Pearl D, Xu Y, Winston J 3rd, Yang GY, Stoner G.   Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study.   Clin Cancer Res.   2011 Feb 1;17(3):598-610.
Huang, Yi-Wen, PhDWang G, Wang Y, Shen C, Huang YW, Huang K, Huang TH, Nephew KP, Li L, Liu Y.  RNA polymerase II binding patterns reveal genomic regions involved in microRNA gene regulation.   PLoS One.   2010;5(11):e13798.
Huang, Yi-Wen, PhDHuang YW, Kuo CT, Stoner K, Huang TH, Wang LS.   An overview of epigenetics and chemoprevention.   FEBS Lett.   2011 Jul 7;585(13):2129-36.
Huang, Yi-Wen, PhDWeng YI, Hsu PY, Liyanarachchi S, Liu J, Deatherage DE, Huang YW, Zuo T, Rodriguez B, Lin CH, Cheng AL, Huang TH.   Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells.   Toxicol Appl Pharmacol.   2010 Oct 15;248(2):111-21.
Huang, Yi-Wen, PhDShu ST, Sugimoto Y, Liu S, Chang HL, Ye W, Wang LS, Huang YW, Yan P, Lin YC.  Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells.   Anticancer Res.   2010 Jun;30(6):1937-46.
Huang, Yi-Wen, PhDYe W, Chang HL, Wang LS, Huang YW, Shu S, Sugimoto Y, Dowd MK, Wan PJ, Lin YC.  Induction of apoptosis by (-)-gossypol-enriched cottonseed oil in human breast cancer cells.   Int J Mol Med.   2010 Jul;26(1):113-9.
Huang, Yi-Wen, PhDHuang YW, Huang TH, Wang LS.   Profiling DNA methylomes from microarray to genome-scale sequencing.   Technol Cancer Res Treat.   2010 Apr;9(2):139-47.
Huang, Yi-Wen, PhDHuang YW, Luo J, Weng YI, Mutch DG, Goodfellow PJ, Miller DS, Huang TH.   Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas.   Gynecol Oncol.   2010 May;117(2):239-47.
Huang, Yi-Wen, PhDChou JL, Su HY, Chen LY, Liao YP, Hartman-Frey C, Lai YH, Yang HW, Deatherage DE, Kuo CT, Huang YW, Yan PS, Hsiao SH, Tai CK, Lin HJ, Davuluri RV, Chao TK, Nephew KP, Huang TH, Lai HC, Chan MW.   Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.   Lab Invest.   2010 Mar;90(3):414-25.
Huang, Yi-Wen, PhDHuang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, Goodfellow PJ, Miller DS, Huang TH.   Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer.   Cancer Res.   2009 Dec 1;69(23):9038-46.
Huang, Yi-Wen, PhDHuang YW, Jansen RA, Fabbri E, Potter D, Liyanarachchi S, Chan MW, Liu JC, Crijns AP, Brown R, Nephew KP, van der Zee AG, Cohn DE, Yan PS, Huang TH, Lin HJ.  Identification of candidate epigenetic biomarkers for ovarian cancer detection.   Oncol Rep.   2009 Oct;22(4):853-61.
Huang, Yi-Wen, PhDChang HL, Sugimoto Y, Liu S, Wang LS, Huang YW, Ye W, Lin YC.   Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.  Anticancer Res.   2009 Aug;29(8):3195-205.
Huang, Yi-Wen, PhDHuang YW, Wang LS, Dowd MK, Wan PJ, Lin YC.   (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.   Anticancer Res.   2009 Jun;29(6):2179-88.
Huang, Yi-Wen, PhDChan MW, Huang YW, Hartman-Frey C, Kuo CT, Deatherage D, Qin H, Cheng AS, Yan PS, Davuluri RV, Huang TH, Nephew KP, Lin HJ.   Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer.   Neoplasia.   2008 Sep;10(9):908-19.
Huang, Yi-Wen, PhDWang LS, Huang YW, Liu S, Yan P, Lin YC.   Conjugated linoleic acid induces apoptosis through estrogen receptor alpha in human breast tissue.   BMC Cancer.   2008;8:208.
Jones, Cresta W., MDHale SA, Jones CW, Osol G, Schonberg A, Badger GJ, Bernstein IM. Sildenafil increases uterine blood flow in nonpregnant nulliparous women. Reprod Sci. 2010 Apr;17(4):358-65.
Klatt, Timothy E., MDKlatt TE, Hopp E. Effect of a best-practice alert on the rate of influenza vaccination of pregnant women. Obstet Gynecol. 2012 Feb;119(2 Pt 1):301-5.
Klatt, Timothy E., MDKlatt TE, Cole DC, Eastwood DC, Barnabei VM. Factors associated with recurrent bacterial vaginosis. J Reprod Med. 2010 Jan-Feb;55(1-2):55-61.
Klatt, Timothy E., MDKlatt TE, Franciosi RA, Cruikshank DP. Normal fetus with a twin presenting as both a complete hydatidiform mole and placenta previa. Obstet Gynecol. 2006 Feb;107(2 Pt 2):527-30.
Koduri, Sumana, MDPham KN, Topp N, Guralnick ML, Koduri S, Newcomer JR, O'Connor RC. Preoperative Valsalva voiding increases the risk of urinary retention after midurethral sling placement. Int Urogynecol J. 2010 Oct;21(10):1243-6.
Koduri, Sumana, MDKuklinski D, Koduri S. Predicting urinary tract infections in a urogynecology population. Urol Nurs. 2008 Feb;28(1):56-60, 67.
Koduri, Sumana, MDKoduri S, Goldberg RP, Kwon C, Dobrez DG, Sand PK. Factors influencing the long-term success of periurethral collagen therapy in the office. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun;17(4):346-51.
Koduri, Sumana, MDGandhi S, Goldberg RP, Kwon C, Koduri S, Beaumont JL, Abramov Y, Sand PK. A prospective randomized trial using solvent dehydrated fascia lata for the prevention of recurrent anterior vaginal wall prolapse. Am J Obstet Gynecol. 2005 May;192(5):1649-54.
Koduri, Sumana, MDGoldberg RP, Koduri S, Sand PK, Kwon C, Culligan P. The tensile strength of Cooper's ligament suturing: comparison of abdominal and transvaginal techniques. Int Urogynecol J Pelvic Floor Dysfunct. 2004 Nov-Dec;15(6):425-7; discussion 428.
Koduri, Sumana, MDGoldberg RP, Tchetgen MB, Sand PK, Koduri S, Rackley R, Appell R, Culligan PJ. Incidence of pubic osteomyelitis after bladder neck suspension using bone anchors. Urology. 2004 Apr;63(4):704-8.
Koduri, Sumana, MDKwon CH, Culligan PJ, Koduri S, Goldberg RP, Sand PK. The development of pelvic organ prolapse following isolated Burch retropubic urethropexy. Int Urogynecol J Pelvic Floor Dysfunct. 2003 Nov;14(5):321-5; discussion 325.
Koduri, Sumana, MDKwon CH, Goldberg RP, Koduri S, Sand PK. The use of intraoperative cystoscopy in major vaginal and urogynecologic surgeries. Am J Obstet Gynecol. 2002 Dec;187(6):1466-71; discussion 1471-2.
Koduri, Sumana, MDCulligan PJ, Koduri S, Heit MH, Rackley R, Thomson RB, Schwabe L, Goldberg RP, Bent AE, Nihira M, Sand PK. The safety of reusing injectable collagen: a multicenter microbiological study. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(4):232-4; discussion 235.
Koduri, Sumana, MDKoduri S, Sand P. Transvaginal bladder neck suspension to Cooper's ligament. Curr Urol Rep. 2001 Oct;2(5):344-9.
Koduri, Sumana, MDGoldberg RP, Koduri S, Lobel RW, Culligan PJ, Tomezsko JE, Winkler HA, Sand PK. Protective effect of suburethral slings on postoperative cystocele recurrence after reconstructive pelvic operation. Am J Obstet Gynecol. 2001 Dec;185(6):1307-12; discussion 1312-3.
Koduri, Sumana, MDCulligan PJ, Goldberg RP, Blackhurst DW, Sasso K, Koduri S, Sand PK. Comparison of microtransducer and fiberoptic catheters for urodynamic studies. Obstet Gynecol. 2001 Aug;98(2):253-7.
Koduri, Sumana, MDGoldberg RP, Tomezsko JE, Winkler HA, Koduri S, Culligan PJ, Sand PK. Anterior or posterior sacrospinous vaginal vault suspension: long-term anatomic and functional evaluation. Obstet Gynecol. 2001 Aug;98(2):199-204.
Koduri, Sumana, MDSand PK, Koduri S, Lobel RW, Winkler HA, Tomezsko J, Culligan PJ, Goldberg R. Prospective randomized trial of polyglactin 910 mesh to prevent recurrence of cystoceles and rectoceles. Am J Obstet Gynecol. 2001 Jun;184(7):1357-62; discussion 1362-4.
Koduri, Sumana, MDKoduri S, Goldberg RP, Sand PK. Transvaginal therapy of genuine stress incontinence. Urology. 2000 Dec 4;56(6 Suppl 1):23-7.
Koduri, Sumana, MDKoduri S, Sand PK. Recent developments in pelvic organ prolapse. Curr Opin Obstet Gynecol. 2000 Oct;12(5):399-404.
Koduri, Sumana, MDCulligan PJ, Rackley R, Koduri S, Thomson RB, Schwabe L, Sand PK. Is it safe to reuse a syringe of glutaraldehyde cross-linked collagen? A microbiological study. J Urol. 2000 Oct;164(4):1275-6.
Kuhlmann, Randall S., MD, PhDBeaulieu DB, Ananthakrishnan AN, Issa M, Rosenbaum L, Skaros S, Newcomer JR, Kuhlmann RS, Otterson MF, Emmons J, Knox J, Binion DG. Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm Bowel Dis. 2009 Jan;15(1):25-8.
Kuhlmann, Randall S., MD, PhDSchellpfeffer MA, Kuhlmann RS, Bolender DL, Ruffolo CG, Kolesari GL. Preliminary investigation of the use of high frequency ultrasound imaging in the chick embryo. Birth Defects Res A Clin Mol Teratol. 2005 Jan;73(1):39-49.
Kuhlmann, Randall S., MD, PhDDe Lia JE, Kuhlmann RS, Emery MG. Maternal metabolic abnormalities in twin-to-twin transfusion syndrome at mid-pregnancy. Twin Res. 2000 Jun;3(2):113-7.
Kuhlmann, Randall S., MD, PhDGaziano EP, De Lia JE, Kuhlmann RS. Diamnionic monochorionic twin gestations: an overview. J Matern Fetal Med. 2000 Mar-Apr;9(2):89-96.
Kuhlmann, Randall S., MD, PhDDe Lia JE, Kuhlmann RS, Lopez KP. Treating previable twin-twin transfusion syndrome with fetoscopic laser surgery: outcomes following the learning curve. J Perinat Med. 1999;27(1):61-7.
Kuhlmann, Randall S., MD, PhDKuhlmann RS, Warsof S. Ultrasound of the placenta. Clin Obstet Gynecol. 1996 Sep;39(3):519-34.
Kuhlmann, Randall S., MD, PhDDe Lia JE, Kuhlmann RS, Harstad TW, Cruikshank DP. Fetoscopic laser ablation of placental vessels in severe previable twin-twin transfusion syndrome. Am J Obstet Gynecol. 1995 Apr;172(4 Pt 1):1202-8; discussion 1208-11.
Kuhlmann, Randall S., MD, PhDLenselink DR, Kuhlmann RS, Lawrence JM, Kolesari GL. Cardiovascular teratogenicity of terbutaline and ritodrine in the chick embryo. Am J Obstet Gynecol. 1994 Aug;171(2):501-6.
Kuhlmann, Randall S., MD, PhDKuhlmann RS, Cruikshank DP. Maternal trauma during pregnancy. Clin Obstet Gynecol. 1994 Jun;37(2):274-93.
Kuhlmann, Randall S., MD, PhDDe Lia JE, Kuhlmann RS, Cruikshank DP, O'Bee LR. Current topic: placental surgery: a new frontier. Placenta. 1993 Sep-Oct;14(5):477-85.
Kuhlmann, Randall S., MD, PhDKuhlmann RS, Werner AL, Abramowicz J, Warsof SL, Arrington J, Levy DL. Placental histology in fetuses between 18 and 23 weeks' gestation with abnormal karyotype. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1264-70.
Kuhlmann, Randall S., MD, PhDShields HE, Kolesari GL, Kuhlmann RS. Tissue and plasma levels of a teratogenic dose of dopamine in the chick embryo following pretreatment with metoprolol or phosphate buffered saline. Life Sci. 1990;46(16):1181-8.
Kuhlmann, Randall S., MD, PhDRajala GM, Kolesari GL, Kuhlmann RS, Schnitzler HJ. Ventricular blood pressure and cardiac output changes in epinephrine- and metoprolol-treated chick embryos. Teratology. 1988 Sep;38(3):291-6.
Kuhlmann, Randall S., MD, PhDKuhlmann RS, Warsof SL, Levy DL, Flake AJ, Harrison MR. Fetal sacrococcygeal teratoma. Fetal Ther. 1987;2(2):95-100.
Kuhlmann, Randall S., MD, PhDRajala GM, Kuhlmann RS, Kolesari GL. The role of dysrhythmic heart function during cardiovascular teratogenesis in epinephrine-treated chick embryos. Teratology. 1984 Dec;30(3):385-92.
Kuhlmann, Randall S., MD, PhDKuhlmann RS, Kolesari GL. The spontaneous occurrence of aortic arch and cardiac malformations in the white Leghorn chick embryo (Gallus domesticus). Teratology. 1984 Aug;30(1):55-9.
Kuhlmann, Randall S., MD, PhDKuhlmann RS, Kolesari GL, Kalbfleisch JH. Reduction of catecholamine-induced cardiovascular malformations in the chick embryo with metoprolol. Teratology. 1983 Aug;28(1):9-14.
Lemen, Paul M., MDLemen PM. Development and assessment of a Web-based evaluation and management coding curriculum for residents. Am J Obstet Gynecol. 2005 Nov;193(5):1785-9.
Lemen, Paul M., MDLemen PM, Wigton TR, Miller-McCarthey AJ, Cruikshank DP. Screening for gestational diabetes mellitus in adolescent pregnancies. Am J Obstet Gynecol. 1998 Jun;178(6):1251-6.
Lund, Michael R., MDFleming MF, Lund MR, Wilton G, Landry M, Scheets D. The Healthy Moms Study: the efficacy of brief alcohol intervention in postpartum women. Alcohol Clin Exp Res. 2008 Sep;32(9):1600-6.
Lund, Michael R., MDBenning BR, Lund MR. Patient knowledge about human papillomavirus and relationship to history of abnormal Papanicolaou test results. J Low Genit Tract Dis. 2007 Jan;11(1):29-34.
Lund, Michael R., MDTonkovic-Capin V, Fleming MG, Kleven-Kranz K, Lund MR. Vulvovaginitis and perineal cellulitis due to group a streptococcus in an adult woman. Arch Dermatol. 2005 Jun;141(6):790-2.
Narayan, Raj, MDNarayan R, Goswamy R. Subendometrial-myometrial contractility in conception and non-conception embryo transfer cycles. Ultrasound Obstet Gynecol. 1994 Nov 1;4(6):499-504.
Narayan, Raj, MDNarayan R, Rajat, Goswamy K. Treatment of submucous fibroids, and outcome of assisted conception. J Am Assoc Gynecol Laparosc. 1994 Aug;1(4 Pt 1):307-11.
Narayan, Raj, MDNarayan R, Goswamy RK. Transvaginal sonography of the uterine cavity with hysteroscopic correlation in the investigation of infertility. Ultrasound Obstet Gynecol. 1993 Mar 1;3(2):129-33.
Newcomer, Julianne R., MDBeaulieu DB, Ananthakrishnan AN, Issa M, Rosenbaum L, Skaros S, Newcomer JR, Kuhlmann RS, Otterson MF, Emmons J, Knox J, Binion DG. Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm Bowel Dis. 2009 Jan;15(1):25-8.
Newcomer, Julianne R., MDPrajapati DN, Newcomer JR, Emmons J, Abu-Hajir M, Binion DG. Successful treatment of an acute flare of steroid-resistant Crohn's colitis during pregnancy with unfractionated heparin. Inflamm Bowel Dis. 2002 May;8(3):192-5.
Newcomer, Julianne R., MDPott-Grinstein E, Newcomer JR. Gynecologists' patterns of prescribing pessaries. J Reprod Med. 2001 Mar;46(3):205-8.
Newcomer, Julianne R., MDNewcomer JR. Ampullary tubal hydatidiform mole treated with linear salpingotomy. A case report. J Reprod Med. 1998 Oct;43(10):913-5.
Peterson, Erika L., MDRaymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011 Aug;66(8):497-506.
Peterson, Erika L., MDPeterson E, Craigo S, House M. Risk factors for postpartum antihypertensive medication requirement in severe preeclampsia. Hypertens Pregnancy. 2010;29(3):350-6.
Peterson, Erika L., MDKempuraj D, Asadi S, Zhang B, Manola A, Hogan J, Peterson E, Theoharides TC. Mercury induces inflammatory mediator release from human mast cells. J Neuroinflammation. 2010;7:20.
Peterson, Erika L., MDTheoharides TC, Zhang B, Kempuraj D, Tagen M, Vasiadi M, Angelidou A, Alysandratos KD, Kalogeromitros D, Asadi S, Stavrianeas N, Peterson E, Leeman S, Conti P. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4448-53.
Quinn, Kristen, MDQuinn KH, Lacoursiere DY, Cui L, Bui J, Parast MM. The unique pathophysiology of early-onset severe preeclampsia: role of decidual T regulatory cells. J Reprod Immunol. 2011 Sep;91(1-2):76-82.
Quinn, Kristen, MDWan JJ, Schrimmer D, Taché V, Quinn K, Lacoursiere DY, James G, Benirschke K, Pretorius DH. Current practices in determining amnionicity and chorionicity in multiple gestations. Prenat Diagn. 2011 Jan;31(1):125-30.
Quinn, Kristen, MDQuinn KH, Cao CT, Lacoursiere DY, Schrimmer D. Monoamniotic twin pregnancy: continuous inpatient electronic fetal monitoring-an impossible goal? Am J Obstet Gynecol. 2011 Feb;204(2):161.e1-6.
Rader, Janet S., MD, FACOGSchwarz JK, Payton JE, Rashmi R, Xiang T, Jia Y, Huettner P, Rogers BE, Yang Q, Watson M, Rader JS, Grigsby PW. Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. Clin Cancer Res. 2012 Mar 1;18(5):1464-71.
Rader, Janet S., MD, FACOGCancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.
Rader, Janet S., MD, FACOGHagemann AR, Zighelboim I, Odibo AO, Rader JS, Mutch DG, Powell MA. Cost-benefit of laparoscopic versus medical ovarian suppression in premenopausal breast cancer. Breast J. 2011 Jan-Feb;17(1):103-5.
Rader, Janet S., MD, FACOGKizer NT, Thaker PH, Gao F, Zighelboim I, Powell MA, Rader JS, Mutch DG, Grigsby PW. The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. Cancer. 2011 Mar 1;117(5):948-56.
Rader, Janet S., MD, FACOGMartin MP, Borecki IB, Zhang Z, Nguyen L, Ma D, Gao X, Qi Y, Carrington M, Rader JS. HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer. Immunogenetics. 2010 Dec;62(11-12):761-5.
Rader, Janet S., MD, FACOGFracasso PM, Williams KJ, Chen RC, Picus J, Ma CX, Ellis MJ, Tan BR, Pluard TJ, Adkins DR, Naughton MJ, Rader JS, Arquette MA, Fleshman JW, Creekmore AN, Goodner SA, Wright LP, Guo Z, Ryan CE, Tao Y, Soares EM, Cai SR, Lin L, Dancey J, Rudek MA, McLeod HL, Piwnica-Worms H. A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies. Cancer Chemother Pharmacol. 2011 Jun;67(6):1225-37.
Rader, Janet S., MD, FACOGKidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, Grigsby PW. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010 Apr 20;28(12):2108-13.
Rader, Janet S., MD, FACOGHu X, Zhang Z, Ma D, Huettner PC, Massad LS, Nguyen L, Borecki I, Rader JS. TP53, MDM2, NQO1, and susceptibility to cervical cancer. Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):755-61.
Rader, Janet S., MD, FACOGHu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X. A microRNA expression signature for cervical cancer prognosis. Cancer Res. 2010 Feb 15;70(4):1441-8.
Rader, Janet S., MD, FACOGZighelboim I, Kizer N, Taylor NP, Case AS, Gao F, Thaker PH, Rader JS, Massad LS, Mutch DG, Powell MA. "Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer. Gynecol Oncol. 2010 Mar;116(3):370-3.
Rader, Janet S., MD, FACOGShowalter TN, Miller TR, Huettner P, Rader J, Grigsby PW. 18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer. Int J Gynecol Cancer. 2009 Nov;19(8):1412-4.
Rader, Janet S., MD, FACOGBrooks R, Kizer N, Nguyen L, Jaishuen A, Wanat K, Nugent E, Grigsby P, Allsworth JE, Rader JS. Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer. Gynecol Oncol. 2010 Mar;116(3):539-43.
Rader, Janet S., MD, FACOGNugent EK, Case AS, Hoff JT, Zighelboim I, DeWitt LL, Trinkhaus K, Mutch DG, Thaker PH, Massad LS, Rader JS. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. Gynecol Oncol. 2010 Mar;116(3):438-41.
Rader, Janet S., MD, FACOGKidd EA, Siegel BA, Dehdashti F, Rader JS, Mutic S, Mutch DG, Powell MA, Grigsby PW. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1085-91.
Rader, Janet S., MD, FACOGNugent EK, Zighelboim I, Case AS, Gao F, Thaker PH, Rader JS, Mutch DG, Massad LS. The value of perioperative imaging in patients with uterine sarcomas. Gynecol Oncol. 2009 Oct;115(1):37-40.
Rader, Janet S., MD, FACOGMassad LS, Jeronimo J, Katki HA, Schiffman M, National Institutes of Health/American Society for Colposcopy and Cervical Pathology Research Group. The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2009 Jul;13(3):137-44.
Rader, Janet S., MD, FACOGKidd EA, Spencer CR, Huettner PC, Siegel BA, Dehdashti F, Rader JS, Grigsby PW. Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake. Cancer. 2009 Aug 1;115(15):3548-54.
Rader, Janet S., MD, FACOGZighelboim I, Schmidt AP, Gao F, Thaker PH, Powell MA, Rader JS, Gibb RK, Mutch DG, Goodfellow PJ. ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes. J Clin Oncol. 2009 Jul 1;27(19):3091-6.
Rader, Janet S., MD, FACOGYu KJ, Rader JS, Borecki I, Zhang Z, Hildesheim A. CD83 polymorphisms and cervical cancer risk. Gynecol Oncol. 2009 Aug;114(2):319-22.
Rader, Janet S., MD, FACOGBrooks RA, Wright JD, Powell MA, Rader JS, Gao F, Mutch DG, Wall LL. Long-term assessment of bladder and bowel dysfunction after radical hysterectomy. Gynecol Oncol. 2009 Jul;114(1):75-9.
Rader, Janet S., MD, FACOGKizer N, Zighelboim I, Rader JS. Cardiac arrest during laparotomy with argon beam coagulation of metastatic ovarian cancer. Int J Gynecol Cancer. 2009 Feb;19(2):237-8.
Rader, Janet S., MD, FACOGWang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA. 2009 Apr;15(4):637-47.
Rader, Janet S., MD, FACOGFowler JM, Brady WE, Grigsby PW, Cohn DE, Mannel RS, Rader JS. Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation. Gynecol Oncol. 2009 Mar;112(3):553-7.
Rader, Janet S., MD, FACOGRader JS, Malone JP, Gross J, Gilmore P, Brooks RA, Nguyen L, Crimmins DL, Feng S, Wright JD, Taylor N, Zighelboim I, Funk MC, Huettner PC, Ladenson JH, Gius D, Townsend RR. A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screening. Proteomics Clin Appl. 2008 Dec;2(12):1658-69.
Rader, Janet S., MD, FACOGBrooks RA, Rader JS, Dehdashti F, Mutch DG, Powell MA, Thaker PH, Siegel BA, Grigsby PW. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynecol Oncol. 2009 Jan;112(1):104-9.
Rader, Janet S., MD, FACOGHerzog TJ, Powell MA, Rader JS, Gibb RK, Lippmann L, Coleman RL, Mutch DG. Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer. Gynecol Oncol. 2008 Dec;111(3):467-73.
Rader, Janet S., MD, FACOGStroud JS, Mutch D, Rader J, Powell M, Thaker PH, Grigsby PW. Effects of cancer treatment on ovarian function. Fertil Steril. 2009 Aug;92(2):417-27.
Rader, Janet S., MD, FACOGWang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One. 2008;3(7):e2557.
Rader, Janet S., MD, FACOGLi J, Olson LM, Zhang Z, Li L, Bidder M, Nguyen L, Pfeifer J, Rader JS. Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancer. Int J Med Sci. 2008;5(3):133-42.
Rader, Janet S., MD, FACOGRader JS, Aylsworth CF, Juckett DA, Mutch DG, Powell MA, Lippmann L, Dimitrov NV. Phase I study and preliminary pharmacology of the novel innate immune modulator rBBX-01 in gynecologic cancers. Clin Cancer Res. 2008 May 15;14(10):3089-97.
Rader, Janet S., MD, FACOGWang SS, Smiraglia DJ, Wu YZ, Ghosh S, Rader JS, Cho KR, Bonfiglio TA, Nayar R, Plass C, Sherman ME. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res. 2008 Apr 1;68(7):2489-97.
Rader, Janet S., MD, FACOGNguyen TT, Wright JD, Powell MA, Gibb RK, Rader JS, Allsworth JE, Mutch DG. Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer. Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1194-9.
Rader, Janet S., MD, FACOGZhang Z, Borecki I, Nguyen L, Ma D, Smith K, Huettner PC, Mutch DG, Herzog TJ, Gibb RK, Powell MA, Grigsby PW, Massad LS, Hernandez E, Judson PL, Swisher EM, Crowder S, Li J, Gerhard DS, Rader JS. CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer. Cancer Res. 2007 Dec 1;67(23):11202-8.
Rader, Janet S., MD, FACOGTierney RM, Powell MA, Mutch DG, Gibb RK, Rader JS, Grigsby PW. Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer. Radiat Med. 2007 Nov;25(9):439-45.
Rader, Janet S., MD, FACOGWright JD, Powell MA, Rader JS, Mutch DG, Gibb RK. Bevacizumab therapy in patients with recurrent uterine neoplasms. Anticancer Res. 2007 Sep-Oct;27(5B):3525-8.
Rader, Janet S., MD, FACOGShivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, Nayar R, Bonfiglio TA, Gazdar AF, Wang SS. Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol. 2007 Dec;107(3):549-53.
Rader, Janet S., MD, FACOGWright JD, Grigsby PW, Rader JS, Mutch DG, Powell MA, Gao F, Gibb RK. Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer. Gynecol Oncol. 2007 Nov;107(2):280-4.
Rader, Janet S., MD, FACOGGius D, Funk MC, Chuang EY, Feng S, Huettner PC, Nguyen L, Bradbury CM, Mishra M, Gao S, Buttin BM, Cohn DE, Powell MA, Horowitz NS, Whitcomb BP, Rader JS. Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Res. 2007 Aug 1;67(15):7113-23.
Rader, Janet S., MD, FACOGWright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F, Rader JS, Mutch DG. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer. 2007 Sep 15;110(6):1281-6.
Rader, Janet S., MD, FACOGWright JD, Secord AA, Numnum TM, Rocconi RP, Powell MA, Berchuck A, Alvarez RD, Gibb RK, Trinkaus K, Rader JS, Mutch DG. A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer. Int J Gynecol Cancer. 2008 May-Jun;18(3):400-6.
Rader, Janet S., MD, FACOGZighelboim I, Goodfellow PJ, Gao F, Gibb RK, Powell MA, Rader JS, Mutch DG. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. J Clin Oncol. 2007 May 20;25(15):2042-8.
Rader, Janet S., MD, FACOGLin LL, Mutch DG, Rader JS, Powell MA, Grigsby PW. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol. 2007 Jul;106(1):215-20.
Rader, Janet S., MD, FACOGFayed A, Mutch DG, Rader JS, Gibb RK, Powell MA, Wright JD, Elnaqa I, Zoberi I, Grigsby PW. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma. Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):480-4.
Rader, Janet S., MD, FACOGZighelboim I, Taylor NP, Powell MA, Gibb RK, Rader JS, Mutch DG, Grigsby PW. Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy. Radiat Med. 2006 Nov;24(9):625-30.
Rader, Janet S., MD, FACOGMcCourt CK, Mutch DG, Gibb RK, Rader JS, Goodfellow PJ, Trinkaus K, Powell MA. Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer. Gynecol Oncol. 2007 Mar;104(3):535-9.
Rader, Janet S., MD, FACOGHebner CM, Wilson R, Rader J, Bidder M, Laimins LA. Human papillomaviruses target the double-stranded RNA protein kinase pathway. J Gen Virol. 2006 Nov;87(Pt 11):3183-93.
Rader, Janet S., MD, FACOGSociety of Gynecologic Oncologists Education Resource Panel Writing group, Collins Y, Einstein MH, Gostout BS, Herzog TJ, Massad LS, Rader JS, Wright J. Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists. Gynecol Oncol. 2006 Sep;102(3):552-62.
Rader, Janet S., MD, FACOGWang SS, Sherman ME, Rader JS, Carreon J, Schiffman M, Baker CC. Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation. Diagn Mol Pathol. 2006 Sep;15(3):144-8.
Rader, Janet S., MD, FACOGTaylor NP, Powell MA, Gibb RK, Rader JS, Huettner PC, Thibodeau SN, Mutch DG, Goodfellow PJ. MLH3 mutation in endometrial cancer. Cancer Res. 2006 Aug 1;66(15):7502-8.
Rader, Janet S., MD, FACOGBaum ME, Rader JS, Gibb RK, McAlister RP, Powell MA, Mutch DG, Gao F, Wright JD. Colposcopic accuracy of obstetrics and gynecology residents. Gynecol Oncol. 2006 Dec;103(3):966-70.
Rader, Janet S., MD, FACOGTaylor NP, Zighelboim I, Huettner PC, Powell MA, Gibb RK, Rader JS, Mutch DG, Edmonston TB, Goodfellow PJ. DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis. Mod Pathol. 2006 Oct;19(10):1333-8.
Rader, Janet S., MD, FACOGHerzog TJ, Powell MA, Rader JS, Gibb R, Mutch DG. Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer. Gynecol Oncol. 2006 Nov;103(2):637-41.
Rader, Janet S., MD, FACOGWright JD, Hagemann A, Rader JS, Viviano D, Gibb RK, Norris L, Mutch DG, Powell MA. Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis. Cancer. 2006 Jul 1;107(1):83-9.
Rader, Janet S., MD, FACOGGrigsby PW, Watson M, Powell MA, Zhang Z, Rader JS. Gene expression patterns in advanced human cervical cancer. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):562-7.
Rader, Janet S., MD, FACOGGossner G, Coleman RL, Mutch DG, Horowitz NS, Rader JS, Gibb RK, Powell MA, Herzog TJ. CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan. Gynecol Oncol. 2006 Oct;103(1):212-8.
Rader, Janet S., MD, FACOGWright JD, Viviano D, Powell MA, Gibb RK, Mutch DG, Grigsby PW, Rader JS. Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer. Gynecol Oncol. 2006 Nov;103(2):489-93.
Rader, Janet S., MD, FACOGFitzpatrick MA, Funk MC, Gius D, Huettner PC, Zhang Z, Bidder M, Ma D, Powell MA, Rader JS. Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data. Gynecol Oncol. 2006 Nov;103(2):458-62.
Rader, Janet S., MD, FACOGZhang Z, Huettner PC, Nguyen L, Bidder M, Funk MC, Li J, Rader JS. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer. Oncogene. 2006 Aug 31;25(39):5436-45.
Rader, Janet S., MD, FACOGWright JD, Rader JS, Davila R, Powell MA, Mutch DG, Gao F, Gibb RK. Human papillomavirus triage for young women with atypical squamous cells of undetermined significance. Obstet Gynecol. 2006 Apr;107(4):822-9.
Rader, Janet S., MD, FACOGWright JD, Rosenbush EJ, Powell MA, Rader JS, Mutch DG, Gao F, Gibb RK. Long-term outcome of women who undergo panniculectomy at the time of gynecologic surgery. Gynecol Oncol. 2006 Jul;102(1):86-91.
Rader, Janet S., MD, FACOGWright JD, Dehdashti F, Herzog TJ, Mutch DG, Huettner PC, Rader JS, Gibb RK, Powell MA, Gao F, Siegel BA, Grigsby PW. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer. 2005 Dec 1;104(11):2484-91.
Rader, Janet S., MD, FACOGWright JD, Powell MA, Mutch DG, Rader JS, Gibb RK, Gao F, Herzog TJ. Relationship of ovarian neoplasms and body mass index. J Reprod Med. 2005 Aug;50(8):595-602.
Rader, Janet S., MD, FACOGLewin SN, Buttin BM, Powell MA, Gibb RK, Rader JS, Mutch DG, Herzog TJ. Resource utilization for ovarian cancer patients at the end of life: how much is too much? Gynecol Oncol. 2005 Nov;99(2):261-6.
Rader, Janet S., MD, FACOGWright JD, Rosenblum K, Huettner PC, Mutch DG, Rader JS, Powell MA, Gibb RK. Cervical sarcomas: an analysis of incidence and outcome. Gynecol Oncol. 2005 Nov;99(2):348-51.
Rader, Janet S., MD, FACOGWright JD, Davila RM, Pinto KR, Merritt DF, Gibb RK, Rader JS, Mutch DG, Gao F, Powell MA. Cervical dysplasia in adolescents. Obstet Gynecol. 2005 Jul;106(1):115-20.
Rader, Janet S., MD, FACOGLamoreaux WT, Grigsby PW, Dehdashti F, Zoberi I, Powell MA, Gibb RK, Rader JS, Mutch DG, Siegel BA. FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):733-7.
Rader, Janet S., MD, FACOGWright JD, Li J, Gerhard DS, Zhang Z, Huettner PC, Powell MA, Gibb RK, Herzog TJ, Mutch DG, Trinkaus KM, Rader JS. Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma. Gynecol Oncol. 2005 Jul;98(1):84-91.
Rader, Janet S., MD, FACOGZhang Z, Gerhard DS, Nguyen L, Li J, Traugott A, Huettner PC, Rader JS. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23. Genes Chromosomes Cancer. 2005 May;43(1):95-103.
Rader, Janet S., MD, FACOGSingh AK, Grigsby PW, Rader JS, Mutch DG, Powell MA. Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):450-5.
Rader, Janet S., MD, FACOGGrigsby PW, Mutch DG, Rader J, Herzog TJ, Zoberi I, Siegel BA, Dehdashti F. Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):444-9.
Rader, Janet S., MD, FACOGLi J, Zhang Z, Bidder M, Funk MC, Nguyen L, Goodfellow PJ, Rader JS. IGSF4 promoter methylation and expression silencing in human cervical cancer. Gynecol Oncol. 2005 Jan;96(1):150-8.
Rader, Janet S., MD, FACOGHorowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, Grigsby PW, Siegel BA, Mutch DG. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol. 2004 Dec;95(3):546-51.
Rader, Janet S., MD, FACOGWright JD, Gibb RK, Geevarghese S, Powell MA, Herzog TJ, Mutch DG, Grigsby PW, Gao F, Trinkaus KM, Rader JS. Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer. 2005 Jan 1;103(1):85-91.
Rader, Janet S., MD, FACOGFracasso PM, Goldstein LJ, de Alwis DP, Rader JS, Arquette MA, Goodner SA, Wright LP, Fears CL, Gazak RJ, Andre VA, Burgess MF, Slapak CA, Schellens JH. Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies. Clin Cancer Res. 2004 Nov 1;10(21):7220-8.
Rader, Janet S., MD, FACOGRutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? Gynecol Oncol. 2004 Oct;95(1):70-6.
Rader, Janet S., MD, FACOGSrokowski T, Pfeifer JD, Li J, Olson LM, Rader JS. Expression and localization of GRP75 in human epithelial tumors and normal tissues. Appl Immunohistochem Mol Morphol. 2004 Jun;12(2):132-8.
Rader, Janet S., MD, FACOGKamelle SA, Rutledge TL, Tillmanns TD, Gould NS, Cohn DE, Wright J, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? Gynecol Oncol. 2004 Aug;94(2):249-55.
Rader, Janet S., MD, FACOGWright JD, Powell MA, Herzog TJ, Mutch DG, Rader JS, Gao F, Gibb RK. Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms. Gynecol Oncol. 2004 Aug;94(2):436-41.
Rader, Janet S., MD, FACOGGrigsby PW, Singh AK, Siegel BA, Dehdashti F, Rader J, Zoberi I. Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):706-12.
Rader, Janet S., MD, FACOGGrigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol. 2004 Jun 1;22(11):2167-71.
Rader, Janet S., MD, FACOGButtin BM, Powell MA, Mutch DG, Babb SA, Huettner PC, Edmonston TB, Herzog TJ, Rader JS, Gibb RK, Whelan AJ, Goodfellow PJ. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet. 2004 Jun;74(6):1262-9.
Rader, Janet S., MD, FACOGPinto KR, Lu DW, Rader JS, Dávila RM. Double cervix with bilateral and synchronous HSIL associated with different high-risk HPV types. A case report. Acta Cytol. 2004 Mar-Apr;48(2):273-7.
Rader, Janet S., MD, FACOGWright JD, Powell MA, Mutch DG, Rader JS, Gibb RK, Huettner PC, Herzog TJ. Synchronous ovarian metastases at the time of laparotomy for colon cancer. Gynecol Oncol. 2004 Mar;92(3):851-5.
Rader, Janet S., MD, FACOGButtin BM, Powell MA, Mutch DG, Rader JS, Herzog TJ, Gibb RK, Huettner P, Edmonston TB, Goodfellow PJ. Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation. Clin Cancer Res. 2004 Jan 15;10(2):481-90.
Rader, Janet S., MD, FACOGLi J, Gerhard DS, Zhang Z, Huettner PC, Wright J, Nguyen L, Lu D, Rader JS. Denaturing high-performance liquid chromatography for detecting and typing genital human papillomavirus. J Clin Microbiol. 2003 Dec;41(12):5563-71.
Rader, Janet S., MD, FACOGRader JS, Clarke-Pearson D, Moore M, Carson L, Holloway R, Kao MS, Wiznitzer I, Douglass EC. A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer. Gynecol Oncol. 2003 Nov;91(2):318-25.
Rader, Janet S., MD, FACOGArmstrong DK, Blessing JA, Rader J, Sorosky JI, Gynecologic Oncology Group Study. A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. Invest New Drugs. 2003 Nov;21(4):453-7.
Rader, Janet S., MD, FACOGWright JD, Powell MA, Rader JS, Pfeifer JD, Huettner PC, Merritt DF. Acute abdominal pain with a calcified pelvic mass. J Pediatr Adolesc Gynecol. 2003 Aug;16(4):237-41.
Rader, Janet S., MD, FACOGWright JD, Herzog TJ, Mutch DG, Gibb RK, Rader JS, Davila RM, Cohn DE. Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignancies. Gynecol Oncol. 2003 Oct;91(1):134-8.
Rader, Janet S., MD, FACOGGerhard DS, Nguyen LT, Zhang ZY, Borecki IB, Coleman BI, Rader JS. A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer. Gynecol Oncol. 2003 Sep;90(3):560-5.
Rader, Janet S., MD, FACOGFracasso PM, Rodriguez LC, Herzog TJ, Fears CL, Goodner SA, Govindan R, Picus J, Rader JS, Tan BR, Arquette MA. Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies. Cancer. 2003 Aug 1;98(3):610-7.
Rader, Janet S., MD, FACOGWhitcomb BP, Mutch DG, Herzog TJ, Rader JS, Gibb RK, Goodfellow PJ. Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. Clin Cancer Res. 2003 Jun;9(6):2277-87.
Rader, Janet S., MD, FACOGGoodfellow PJ, Buttin BM, Herzog TJ, Rader JS, Gibb RK, Swisher E, Look K, Walls KC, Fan MY, Mutch DG. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U S A. 2003 May 13;100(10):5908-13.
Rader, Janet S., MD, FACOGWright JD, Horowitz NS, Rader JS. Primary peritoneal carcinoma presenting as adenocarcinoma on a Pap smear. A case report. J Reprod Med. 2002 Nov;47(11):933-5.
Rader, Janet S., MD, FACOGFracasso PM, Rader JS, Govindan R, Herzog TJ, Arquette MA, Denes A, Mutch DG, Picus J, Tan BR, Fears CL, Goodner SA, Sun SL. Phase I study of rubitecan and gemcitabine in patients with advanced malignancies. Ann Oncol. 2002 Nov;13(11):1819-25.
Rader, Janet S., MD, FACOGPowell MA, Mutch DG, Rader JS, Herzog TJ, Huang TH, Goodfellow PJ. Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker. Cancer. 2002 Jun 1;94(11):2941-52.
Rader, Janet S., MD, FACOGWhelan AJ, Babb S, Mutch DG, Rader J, Herzog TJ, Todd C, Ivanovich JL, Goodfellow PJ. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers. Int J Cancer. 2002 Jun 10;99(5):697-704.
Rader, Janet S., MD, FACOGHorowitz NS, Cohn DE, Herzog TJ, Mutch DG, Rader JS, Bhalla S, Gibb RK. The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies. Gynecol Oncol. 2002 Jul;86(1):79-84.
Rader, Janet S., MD, FACOGHorowitz N, Pinto K, Mutch DG, Herzog TJ, Rader JS, Gibb R, Bocker-Edmonston T, Goodfellow PJ. Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia. Gynecol Oncol. 2002 Jul;86(1):62-8.
Rader, Janet S., MD, FACOGIvanovich J, Babb S, Goodfellow P, Mutch D, Herzog T, Rader J, Whelan A. Evaluation of the family history collection process and the accuracy of cancer reporting among a series of women with endometrial cancer. Clin Cancer Res. 2002 Jun;8(6):1849-56.
Rader, Janet S., MD, FACOGAlvi AJ, Hogg R, Rader JS, Kuo MJ, Maher ER, Latif F. Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer. Mol Pathol. 2002 Jun;55(3):153-5.
Rader, Janet S., MD, FACOGHorowitz NS, Gibb RK, Menegakis NE, Mutch DG, Rader JS, Herzog TJ. Utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients. Obstet Gynecol. 2002 May;99(5 Pt 1):771-6.
Rader, Janet S., MD, FACOGCohn DE, Dehdashti F, Gibb RK, Mutch DG, Rader JS, Siegel BA, Herzog TJ. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol. 2002 Apr;85(1):179-84.
Rader, Janet S., MD, FACOGBloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, Markman M, Benda J. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol. 2002 Apr 1;20(7):1832-7.
Rader, Janet S., MD, FACOGSwisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, Mutch DG. Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol. 2002 Mar;84(3):363-7.
Rader, Janet S., MD, FACOGPlaxe SC, Blessing JA, Husseinzadeh N, Webster KD, Rader JS, Dunton CJ. Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol. 2002 Feb;84(2):241-4.
Rader, Janet S., MD, FACOGButtin BM, Herzog TJ, Powell MA, Rader JS, Mutch DG. Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstet Gynecol. 2002 Jan;99(1):11-7.
Rader, Janet S., MD, FACOGHorowitz NS, Rader JS. Role of the ultrasonic surgical aspirator in gynecology. Obstet Gynecol Clin North Am. 2001 Dec;28(4):775-90.
Rader, Janet S., MD, FACOGCohn DE, Mutch DG, Herzog TJ, Rader JS, Dintzis SM, Gersell DJ, Todd CR, Goodfellow PJ. Genotypic and phenotypic progression in endometrial tumorigenesis: determining when defects in DNA mismatch repair and KRAS2 occur. Genes Chromosomes Cancer. 2001 Dec;32(4):295-301.
Rader, Janet S., MD, FACOGCohn DE, Mutch DG, Rader JS, Farrell M, Awantang R, Herzog TJ. Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies. Gynecol Oncol. 2001 Dec;83(3):533-6.
Rader, Janet S., MD, FACOGAlvi AJ, Rader JS, Broggini M, Latif F, Maher ER. Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer. Mol Pathol. 2001 Aug;54(4):240-3.
Rader, Janet S., MD, FACOGO'sullivan MJ, Rader JS, Gerhard DS, Li Y, Trinkaus KM, Gersell DJ, Huettner PC. Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix. Hum Pathol. 2001 May;32(5):475-8.
Rader, Janet S., MD, FACOGAgathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene. 2001 Mar 22;20(12):1509-18.
Rader, Janet S., MD, FACOGSwisher EM, Babb S, Whelan A, Mutch DG, Rader JS. Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction. J Reprod Med. 2001 Feb;46(2):87-94.
Rader, Janet S., MD, FACOGKulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res. 2001 Feb;7(2):429-34.
Rader, Janet S., MD, FACOGCohn D, Mutch D, Elbendary A, Rader J, Herzog T, Goodfellow P. No evidence for BCL10 mutation in endometrial cancers with microsatellite instability. Hum Mutat. 2001 Feb;17(2):117-21.
Rader, Janet S., MD, FACOGGrigsby PW, Perez CA, Chao KS, Herzog T, Mutch DG, Rader J. Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):733-8.
Rader, Janet S., MD, FACOGBasil JB, Goodfellow PJ, Rader JS, Mutch DG, Herzog TJ. Clinical significance of microsatellite instability in endometrial carcinoma. Cancer. 2000 Oct 15;89(8):1758-64.
Rader, Janet S., MD, FACOGCohn DE, Swisher EM, Herzog TJ, Rader JS, Mutch DG. Radical hysterectomy for cervical cancer in obese women. Obstet Gynecol. 2000 Nov;96(5 Pt 1):727-31.
Rader, Janet S., MD, FACOGCohn DE, Basil JB, Venegoni AR, Mutch DG, Rader JS, Herzog TJ, Gersell DJ, Goodfellow PJ. Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability. Gynecol Oncol. 2000 Oct;79(1):101-6.
Rader, Janet S., MD, FACOGBasil JB, Rader JS. Management of women at risk for malignancy. Curr Opin Oncol. 2000 Sep;12(5):508-13.
Rader, Janet S., MD, FACOGCohn DE, Babb S, Whelan AJ, Mutch DG, Herzog TJ, Rader JS, Elbendary A, Goodfellow PJ. Atypical clustering of gynecologic malignancies: A family study including molecular analysis of candidate genes. Gynecol Oncol. 2000 Apr;77(1):18-25.
Rader, Janet S., MD, FACOGRader JS, Li Y, Huettner PC, Xu Z, Gerhard DS. Cervical cancer suppressor gene is within 1 cM on 6p23. Genes Chromosomes Cancer. 2000 Apr;27(4):373-9.
Rader, Janet S., MD, FACOGSchilder RJ, Blessing JA, Morgan M, Mangan CE, Rader JS. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group. Gynecol Oncol. 2000 Feb;76(2):204-7.
Rader, Janet S., MD, FACOGNeuman RJ, Huettner PC, Li L, Mardis ER, Duffy BF, Wilson RK, Rader JS. Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls. Obstet Gynecol. 2000 Jan;95(1):134-40.
Rader, Janet S., MD, FACOGGrigsby PW, Perez CA, Chao KS, Elbendary A, Herzog TJ, Rader JS, Mutch DG. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery. Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):645-51.
Rader, Janet S., MD, FACOGFullwood P, Marchini S, Rader JS, Martinez A, Macartney D, Broggini M, Morelli C, Barbanti-Brodano G, Maher ER, Latif F. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res. 1999 Sep 15;59(18):4662-7.
Rader, Janet S., MD, FACOGBasil JB, Swisher EM, Herzog TJ, Rader JS, Elbendary A, Mutch DG, Goodfellow PJ. Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability. Gynecol Oncol. 1999 Sep;74(3):395-9.
Rader, Janet S., MD, FACOGSwisher EM, Peiffer-Schneider S, Mutch DG, Herzog TJ, Rader JS, Elbendary A, Goodfellow PJ. Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability. Cancer. 1999 Jan 1;85(1):119-26.
Rader, Janet S., MD, FACOGRader JS, Neuman RJ, Brady J, Babb S, Temple S, Kost E, Mutch DG, Herzog TJ. Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer. Obstet Gynecol. 1998 Oct;92(4 Pt 1):589-95.
Rader, Janet S., MD, FACOGPeiffer-Schneider S, Noonan FC, Mutch DG, Simpkins SB, Herzog T, Rader J, Elbendary A, Gersell DJ, Call K, Goodfellow PJ. Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus deletion interval. Genomics. 1998 Aug 15;52(1):9-16.
Rader, Janet S., MD, FACOGSwisher EM, Mutch DG, Herzog TJ, Rader JS, Kowalski LD, Elbendary A, Goodfellow PJ. Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair. J Soc Gynecol Investig. 1998 Jul-Aug;5(4):210-6.
Rader, Janet S., MD, FACOGRader JS, Gerhard DS, O'Sullivan MJ, Li Y, Li L, Liapis H, Huettner PC. Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p. Genes Chromosomes Cancer. 1998 May;22(1):57-65.
Rader, Janet S., MD, FACOGHuettner PC, Gerhard DS, Li L, Gersell DJ, Dunnigan K, Kamarasova T, Rader JS. Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features. Hum Pathol. 1998 Apr;29(4):364-70.
Rader, Janet S., MD, FACOGSwisher EM, Mutch DG, Rader JS, Elbendary A, Herzog TJ. Topotecan in platinum- and paclitaxel-resistant ovarian cancer. Gynecol Oncol. 1997 Sep;66(3):480-6.
Rader, Janet S., MD, FACOGLiapis H, Adler LM, Wick MR, Rader JS. Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. Hum Pathol. 1997 Apr;28(4):443-9.
Rader, Janet S., MD, FACOGKowalski LD, Mutch DG, Herzog TJ, Rader JS, Goodfellow PJ. Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers. Genes Chromosomes Cancer. 1997 Mar;18(3):219-27.
Rader, Janet S., MD, FACOGRader JS, Kamarasova T, Huettner PC, Li L, Li Y, Gerhard DS. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene. 1996 Dec 19;13(12):2737-41.
Rader, Janet S., MD, FACOGHerzog TJ, Williams S, Adler LM, Rader JS, Kubiniec RT, Camel HM, Mutch DG. Potential of cervical electrosurgical excision procedure for diagnosis and treatment of cervical intraepithelial neoplasia. Gynecol Oncol. 1995 Jun;57(3):286-93.
Rader, Janet S., MD, FACOGBall RH, Picus D, Goyal RK, Wilson DB, Rader JS. Ovarian artery pseudoaneurysm: diagnosis by Doppler sonography and treatment with transcatheter embolization. J Ultrasound Med. 1995 Mar;14(3):250-2.
Rader, Janet S., MD, FACOGAdler LM, Herzog TJ, Williams S, Rader JS, Mutch DG. Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines. Cancer. 1994 Oct 1;74(7):1891-8.
Rader, Janet S., MD, FACOGLiapis H, Crouch EC, Roby J, Rader JS. In situ localization of parathyroid hormone-like protein and mRNA in intraepithelial neoplasia and invasive carcinoma of the uterine cervix. Hum Pathol. 1993 Oct;24(10):1058-66.
Rader, Janet S., MD, FACOGRader JS, Rest EB, Farmer ER, Rosenshein NB. A comparison of wound healing after epithelial resection by ultrasonic surgical aspiration and ablation by the carbon dioxide laser. Gynecol Oncol. 1992 Sep;46(3):351-6.
Rader, Janet S., MD, FACOGRader JS. Therapeutic advances in ovarian cancer. Curr Opin Obstet Gynecol. 1992 Feb;4(1):120-7.
Rader, Janet S., MD, FACOGPark JS, Rader JS, Wu TC, Laimins LA, Currie JL, Kurman RJ, Shah KV. HPV-16 viral transcripts in vulvar neoplasia: preliminary studies. Gynecol Oncol. 1991 Sep;42(3):250-5.
Rader, Janet S., MD, FACOGLeake JF, Rader JS, Woodruff JD, Rosenshein NB. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol. 1991 Aug;42(2):124-30.
Rader, Janet S., MD, FACOGCoutlée F, Shah KV, Rader JS, Currie JL, Viscidi RP. Detection of transcripts of human papillomaviruses 16 and 18 in cancer-derived cell lines and cervical biopsies by enzyme immunoassay for DNA-RNA hybrids following solution hybridization. J Clin Microbiol. 1991 May;29(5):968-74.
Rader, Janet S., MD, FACOGRader JS, Leake JF, Dillon MB, Rosenshein NB. Ultrasonic surgical aspiration in the treatment of vulvar disease. Obstet Gynecol. 1991 Apr;77(4):573-6.
Rader, Janet S., MD, FACOGRader JS, Rosenzweig BA, Spirtas R, Padleckas R, Javaheri G, Gerardo L, Laimins LA. Atypical squamous cells. A case-series study of the association between papanicolaou smear results and human papillomavirus DNA genotype. J Reprod Med. 1991 Apr;36(4):291-7.
Rader, Janet S., MD, FACOGRader JS, Binette SP, Brandt TD, Sreekanth S, Chhablani A. Ileal hemorrhage caused by a parasitic uterine leiomyoma. Obstet Gynecol. 1990 Sep;76(3 Pt 2):531-4.
Rader, Janet S., MD, FACOGRader JS, Haraf DJ, Halpern HJ, Rotmensch J, Spelbring DR, Sutton H, Javaheri G, Weichselbaum RR. Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience. J Surg Oncol. 1990 Jul;44(3):157-65.
Rader, Janet S., MD, FACOGRader JS, Golub TR, Hudson JB, Patel D, Bedell MA, Laimins LA. In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions. Oncogene. 1990 Apr;5(4):571-6.
Rader, Janet S., MD, FACOGDudzinski MR, Rader JS. The mons pubis: an excellent graft donor site in gynecologic surgery. Am J Obstet Gynecol. 1990 Mar;162(3):722-5.
Strawn, Estil Y., Jr., MDLau EC, Janson MM, Roesler MR, Avner ED, Strawn EY, Bick DP. Birth of a healthy infant following preimplantation PKHD1 haplotyping for autosomal recessive polycystic kidney disease using multiple displacement amplification. J Assist Reprod Genet. 2010 Jul;27(7):397-407.
Strawn, Estil Y., Jr., MDStrawn EY Jr, Bick D, Swanson A. Is it the patient or the IVF? Beckwith-Wiedemann syndrome in both spontaneous and assisted reproductive conceptions. Fertil Steril. 2010 Jul;94(2):754.e1-2.
Strawn, Estil Y., Jr., MDBick SL, Bick DP, Wells BE, Roesler MR, Strawn EY, Lau EC. Preimplantation HLA haplotyping using tri-, tetra-, and pentanucleotide short tandem repeats for HLA matching. J Assist Reprod Genet. 2008 Jul;25(7):323-31.
Strawn, Estil Y., Jr., MDKlinkner DB, Lim HJ, Strawn EY Jr, Oldham KT, Sander TL. An in vivo murine model of rosiglitazone use in pregnancy. Fertil Steril. 2006 Oct;86(4 Suppl):1074-9.
Strawn, Estil Y., Jr., MDHo HM, Ohshima K, Watanabe G, Taya K, Strawn EY, Hutz RJ. TCDD increases inhibin A production by human luteinized granulosa cells in vitro. J Reprod Dev. 2006 Aug;52(4):523-8.
Strawn, Estil Y., Jr., MDStrawn EY Jr, Roesler M, Rinke M, Aiman EJ. Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates. Am J Obstet Gynecol. 2000 Jun;182(6):1623-8.
Strawn, Estil Y., Jr., MDGarcha IS, Perloe M, Strawn EY, Mason EM. Laparoscopic resection of sigmoid endometrioma. Am Surg. 1996 Apr;62(4):274-5.
Strawn, Estil Y., Jr., MDStrawn EY Jr, Novy MJ, Burry KA, Bethea CL. Insulin-like growth factor I promotes leiomyoma cell growth in vitro. Am J Obstet Gynecol. 1995 Jun;172(6):1837-43; discussion 1843-4.
Strawn, Estil Y., Jr., MDBrandon DD, Erickson TE, Keenan EJ, Strawn EY, Novy MJ, Burry KA, Warner C, Clinton GM. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab. 1995 Jun;80(6):1876-81.
Strawn, Estil Y., Jr., MDBrandon DD, Bethea CL, Strawn EY, Novy MJ, Burry KA, Harrington MS, Erickson TE, Warner C, Keenan EJ, Clinton GM. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol. 1993 Jul;169(1):78-85.
Strawn, Estil Y., Jr., MDHaning RV Jr, Strawn EY, Nolten WE. Pathophysiology of the ovarian hyperstimulation syndrome. Obstet Gynecol. 1985 Aug;66(2):220-4.
Uyar, Denise S., MDUyar DS, Eltabbakh GH, Mount SL.   Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant.   Gynecol Oncol.   2003 May;89(2):227-32.